Vyndamax 61 MG capsule UD 30S
Ended Awarded
- Contract number
- SPE2DB25FE0ZU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $83,082
Award facts
- Contract value 100% obligated
- $83,081.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $83,081.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). This non-set-aside contract, issued on September 24, 2025, with an ultimate completion date of October 16, 2025, will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Vyndamax is a brand-name pharmaceutical product used primarily for the treatment of transthyretin cardiac amyloidosis, a rare but serious cardiac condition, and represents part of the DLA's ongoing efforts to supply specialized medications to support military healthcare systems.
This delivery order is executed under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical supply vehicle enables the company to deliver a broad range of brand-name and generic medications, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems globally. As a major pharmaceutical distributor and established federal vendor, AmerisourceBergen Drug Corp regularly fulfills specialized medical procurement requirements through competitive awards under the DLA's medical supply chain, demonstrating its capability to meet complex pharmaceutical distribution needs across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FE0ZU?
SPE2DB25FE0ZU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FE0ZU worth?
The government has obligated $83,082 on SPE2DB25FE0ZU.
Is contract SPE2DB25FE0ZU an order under another contract?
Yes. SPE2DB25FE0ZU is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE0ZU competed?
The extent of competition for SPE2DB25FE0ZU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award